SNN Stock Summary and Trading Ideas (Smith & Nephew Snats | NYSE:SNN)

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Snats trades on the NYSE stock market under the symbol SNN.

As of June 18, 2026, SNN stock price climbed to $30.08 with 845,795 million shares trading.

SNN has a beta of 0.96, meaning it tends to be less sensitive to market movements. SNN has a correlation of 0.17 to the broad based SPY ETF.

SNN has a market cap of $12.74 billion. This is considered a Large Cap stock.

Last quarter Smith & Nephew Snats reported $6 billion in Revenue and $1.02 earnings per share. This beat revenue expectation by $3 billion and missed earnings estimates by -$.87.

In the last 3 years, SNN traded as high as $38.79 and as low as $21.53.

The top ETF exchange traded funds that SNN belongs to (by Net Assets): DFIC, AVDE, BINV, DFAX, KOMP.

SNN has underperformed the market in the last year with a price return of +8.0% while the SPY ETF gained +26.9%. SNN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.2% and -2.5%, respectively, while the SPY returned +13.5% and -1.1%, respectively.

SNN support price is $29.68 and resistance is $30.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNN shares will trade within this expected range on the day.